Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Blood (2023) 142 (Supplement 1): 7016.

https://doi.org/10.1182/blood-2023-177866

Published: 2023

Journal Articles

Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma

Blood (2023) 142 (Supplement 1): 3592.

https://doi.org/10.1182/blood-2023-184945

Published: 2023

Journal Articles

HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party

Blood (2023) 142 (Supplement 1): 2178.

https://doi.org/10.1182/blood-2023-185945

Published: 2023

Journal Articles

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party

Blood (2021) 138 (Supplement 1): 3937.

https://doi.org/10.1182/blood-2021-147001

Published: 2021

Journal Articles

Transplant Outcomes in Patients with Ph+ Chronic Myeloid Leukemia: Haploidentical Donors Compared to Matched Sibling Donors and Matched/Mismatched Unrelated Donors: A Retrospective Analysis from the EBMT Chronic Malignancies Working Party (EBMT-CMWP)

Blood (2021) 138 (Supplement 1): 3959.

https://doi.org/10.1182/blood-2021-146366

Published: 2021

Journal Articles

Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT

Blood (2020) 136 (Supplement 1): 45–47.

https://doi.org/10.1182/blood-2020-142397

Published: 2020

Journal Articles

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Blood (2019) 134 (Supplement_1): 3281.

https://doi.org/10.1182/blood-2019-125369

Published: 2019

Journal Articles

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Blood (2018) 132 (Supplement 1): 3425.

https://doi.org/10.1182/blood-2018-99-113824

Published: 2018

Journal Articles

Impact of Upfront Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma with Del(17) and t(4;14): A Report from the EBMT Chronic Malignancies Working Party

Blood (2018) 132 (Supplement 1): 2143.

https://doi.org/10.1182/blood-2018-99-115372

Published: 2018

Journal Articles

Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study

Krista Vaht, MD, Magnus Göransson, MD PhD, Kristina Carlson, MD PhD, Cecilia Isaksson, MD, Stig Lenhoff, Anna Sandstedt, MD, Bertil Uggla, MD PhD, Per T. Ljungman, MD PhD, Mats Brune, MD PhD, Per-Ola Andersson, MD PhD

Blood (2016) 128 (22): 3905.

https://doi.org/10.1182/blood.V128.22.3905.3905

Published: 2016

Journal Articles

Impact of Extramedullary Disease in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: A Study By the EBMT Chronic Malignancies Working Party

Blood (2016) 128 (22): 2266.

https://doi.org/10.1182/blood.V128.22.2266.2266

Published: 2016

Journal Articles

Comparison of Haematopoietic Stem Cell Transplantation Approaches in Primary Plasma Cell Leukaemia

Blood (2016) 128 (22): 2293.

https://doi.org/10.1182/blood.V128.22.2293.2293

Published: 2016

Journal Articles

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Charalampia Kyriakou, Ariane Boumendil, PhD, Herve Finel, Norbert Schmitz, MD, PhD, Henrik Sengeloev, MD, Stephen Mackinnon, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Paul Browne, MD, Charles Craddock, MD PhD, Dietger W. Niederwieser, MD, Johannes Schetelig, MD PhD, Stig Lenhoff, Nathalie Fegueux, MD, Silvia Montoto, MD, Peter Dreger, MD PhD

Blood (2016) 128 (22): 4661.

https://doi.org/10.1182/blood.V128.22.4661.4661

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience

Blood (2015) 126 (23): 4403.

https://doi.org/10.1182/blood.V126.23.4403.4403

Published: 2015

Journal Articles

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

Blood (2015) 126 (17): 2062–2069.

https://doi.org/10.1182/blood-2015-06-651562

Published: 2015

Includes: Supplemental data

Journal Articles

Allogeneic HCT in Patients with 17p-CLL: Results of a Non-Interventional Study of the EBMT & Eric

Johannes Schetelig, MD M. Sc,, Jennifer Hoek, Stephan Stilgenbauer, MD, Martin Bornhäuser, MD, Niels S. Andersen, MD, Christopher P Fox, MD, Stig Lenhoff, MD, Donald W. Bunjes, MD, Liisa Volin, MD, Avichai Shimoni, MD, Wilfried A Schroyens, Michel van Gelder, MD, Anja van Biezen, Liesbeth de Wreede, PhD, Theo M de Witte, MD, Nicolaus Kröger, MD, Peter Dreger, MD

Blood (2014) 124 (21): 1224.

https://doi.org/10.1182/blood.V124.21.1224.1224

Published: 2014

Journal Articles

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Blood (2013) 121 (23): 4647–4654.

https://doi.org/10.1182/blood-2012-11-464503

Published: 2013

Journal Articles

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Curly Morris, MD, Simona Iacobelli, Gosta Gahrton, MD, Laurent Garderet, MD, Mary Drake, MBBCh, MD, Anja van Biezen, Mohamad Mohty, Didier Blaise, MD, Xavier Poiré, M.D, Marie José Kersten, Noel-Jean Milpied, MD, Stig Lenhoff, MD, PhD, Nigel H. Russell, MD, J.ürgen Finke, T. M. de Witte, MD, PhD

Blood (2011) 118 (21): 2008.

https://doi.org/10.1182/blood.V118.21.2008.2008

Published: 2011

Journal Articles

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Philadelphia Chromosome Acute Lymphoblastic Leukemia (Ph+ALL) in First Complete Remission (CR1) At the Era of Tyrosine Kinase Inhibitors (TKI): A Survey From the Acute Leukemia Working Party (ALWP) of EBMT,

Eolia Brissot, Myriam Labopin, MD, MS, Gérard Socié, Liisa Volin, Alessandro Rambaldi, Dietrich Beelen, Nicolaus Kroeger, Stig Lenhoff, Jurgen Finke, MD, Jordi Esteve, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 4107.

https://doi.org/10.1182/blood.V118.21.4107.4107

Published: 2011

Journal Articles

Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATCL): A Retrospective Study of the European Group for Blood and Marrow Transplantation (EBMT)

Esa Jantunen, Ariane Boumendil, Alessandro Rambaldi, Marc Schapira, Jian Jian Luan, Martin Gramatzki, Stig Lenhoff, Gunnar J. Oberg, Peter Dreger, Anna Sureda, on behalf of the Lymphoma WP of the EBMT

Blood (2011) 118 (21): 3115.

https://doi.org/10.1182/blood.V118.21.3115.3115

Published: 2011

NARROW

Graft-Versus-Host Disease (GvHD) and Steroid-Refractory GvHD after Allogeneic Hematopoietic Stem Cell Transplantation: A Large Real-World EBMT-Based Epidemiology and Treatment Pattern Study

Salvage Transplant Versus CAR-T Cell Therapy for Relapsed Multiple Myeloma

HLA Class I Mismatches Reduce Survival after HCT in the Ptcy Era: A Study By the EBMT Cellular Therapy and Immunobiology Working Party

A Novel Early Relapse Prediction Score Based on Age, ISS and Disease Status at the Time of Transplant in Patients with Newly Diagnosed Multiple Myeloma. a Study of the EBMT Chronic Malignancies Working Party

Transplant Outcomes in Patients with Ph+ Chronic Myeloid Leukemia: Haploidentical Donors Compared to Matched Sibling Donors and Matched/Mismatched Unrelated Donors: A Retrospective Analysis from the EBMT Chronic Malignancies Working Party (EBMT-CMWP)

Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT

Association of Donor-Recipient HLA Matching with Outcome of Unrelated Donor Hematopoietic Stem Cell Transplantation: A Study from the Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Results of Autologous and Allogeneic Transplantation in Patients with Primary Plasma Cell Leukemia: A Large Retrospective Analysis of the Chronic Malignancies Working Party of the EBMT

Impact of Upfront Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma with Del(17) and t(4;14): A Report from the EBMT Chronic Malignancies Working Party

Incidence and Outcome in Aplastic Anemia Diagnosed 2000-2011 - a Nationwide Swedish Registry Study

Impact of Extramedullary Disease in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: A Study By the EBMT Chronic Malignancies Working Party

Comparison of Haematopoietic Stem Cell Transplantation Approaches in Primary Plasma Cell Leukaemia

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience

Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantation

Allogeneic HCT in Patients with 17p-CLL: Results of a Non-Interventional Study of the EBMT & Eric

Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) for Philadelphia Chromosome Acute Lymphoblastic Leukemia (Ph+ALL) in First Complete Remission (CR1) At the Era of Tyrosine Kinase Inhibitors (TKI): A Survey From the Acute Leukemia Working Party (ALWP) of EBMT,

Autologous Stem Cell Transplantation (ASCT) for Enteropathy-Associated T-Cell Lymphoma (EATCL): A Retrospective Study of the European Group for Blood and Marrow Transplantation (EBMT)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only